Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Launches 50 SKUs across classical Ayurveda formulations, OTC products, and medical foods
Apollo AyurVAID has announced its strategic foray into the Ayurveda product segment, marking a significant expansion beyond clinical care. The new portfolio spans classical formulations, OTC products, and medical foods.
Apollo AyurVAID’s product range features clinically proven formulations that are certified safe by NABL-accredited laboratories with respect to the presence of heavy metals, aflatoxins, microbial content, etc., as applicable for different product types.
Apollo AyurVAID’s products set the highest, proof-backed, safety benchmark in the Ayurveda product market with the consumer able to verify test results (QR code on packaging) for every product they consume.
Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals and Chairperson, Apollo AyurVAID said, “Apollo AyurVAID’s foray into tested-safe Ayurveda products marks a pivotal step in redefining standards of safety, transparency, and efficacy in traditional medicine. This expansion builds on a strong foundation of clinical excellence and reflects a deep commitment to evidence-based, precision Ayurveda.”
Rajiv Vasudevan, Founder, MD, and CEO, Apollo AyurVAID said, “This new vertical not only complements our inpatient-outpatient care model but also opens scalable revenue opportunities and reinforces our vision of mainstreaming evidence-based Ayurveda services and products by making it accessible globally. We anticipate this portfolio will be a key growth driver, with a revenue aspiration of ₹500 crores in the next five years.”
The OTC and medical foods lines will be available through a wide network of retail and digital platforms. The OTC range features innovative medicine formats such as creams, transdermal pads, essential extracts, etc., for special customer segments (women, child, elder, etc.) and applications (pain, sleep, stress, skin etc.), with the highest medical content assuring best-in-class product performance.
Apollo AyurVAID has recently partnered with integrated systems biology platform company, Avesthagen Limited, to co-develop and offer scientifically validated, botanical-actives-based dietary supplements that are sugar-free, artificial colour and flavours free; this shall be followed with an Ayurveda-based medical foods range for specific clinical indications.
“In the current fiscal we plan to expand our hospital network in an asset-light manner by adding nine new points of presence, scaling our bed capacity to 350, aiming to treat over 50,000 patients. With a CAGR of 75 per cent over the last two to three years, we are on track to surpass the annualised Rs 100 crore revenue mark by mid-next year – an unprecedented milestone in Ayurveda’s services sector,” added Vasudevan.